Your search returned 9 results.

Results
	1.	Src family kinase inhibitor Saracatinib (AZD0530) impairs oxaliplatin uptake in colorectal cancer cells and blocks organic cation transporters. [electronic resource] by Morrow, Christopher J Ghattas, Mohammad Smith, Christopher Bönisch, Heinz Bryce, Richard A Hickinson, D Mark Green, Tim P Dive, Caroline Producer: 20100824 In: Cancer research vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	5-Substituted 4-anilinoquinazolines as potent, selective and orally active inhibitors of erbB2 receptor tyrosine kinase. [electronic resource] by Ballard, Peter Bradbury, Robert H Hennequin, Laurent F A Hickinson, D Mark Johnson, Paul D Kettle, Jason G Klinowska, Teresa Morgentin, Remy Ogilvie, Donald J Olivier, Annie Producer: 20051220 In: Bioorganic & medicinal chemistry letters vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer. [electronic resource] by Hickinson, D Mark Klinowska, Teresa Speake, Georgina Vincent, John Trigwell, Cath Anderton, Judith Beck, Sarah Marshall, Gayle Davenport, Sara Callis, Rowena Mills, Elizabeth Grosios, Konstantina Smith, Paul Barlaam, Bernard Wilkinson, Robert W Ogilvie, Donald Producer: 20100426 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors. [electronic resource] by Barlaam, Bernard Anderton, Judith Ballard, Peter Bradbury, Robert H Hennequin, Laurent F A Hickinson, D Mark Kettle, Jason G Kirk, George Klinowska, Teresa Lambert-van der Brempt, Christine Trigwell, Cath Vincent, John Ogilvie, Donald Producer: 20140605 In: ACS medicinal chemistry letters vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib. [electronic resource] by Hickinson, D Mark Marshall, Gayle B Beran, Garry J Varella-Garcia, Marileila Mills, Elizabeth A South, Marie C Cassidy, Andrew M Acheson, Kerry L McWalter, Gael McCormack, Rose M Bunn, Paul A French, Tim Graham, Alex Holloway, Brian R Hirsch, Fred R Speake, Georgina Producer: 20100730 In: Clinical and translational science vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. [electronic resource] by Ballard, Peter Barlaam, Bernard C Bradbury, Robert H Dishington, Allan Hennequin, Laurent F A Hickinson, D Mark Hollingsworth, Ian M Kettle, Jason G Klinowska, Teresa Ogilvie, Donald J Pearson, Stuart E Scott, James S Suleman, Abid Whittaker, Robin Williams, Emma J Wood, Robin Wright, Lindsay Producer: 20080623 In: Bioorganic & medicinal chemistry letters vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer. [electronic resource] by Brave, Sandra R Odedra, Rajesh James, Neil H Smith, Neil R Marshall, Gayle B Acheson, Kerry L Baker, Dawn Howard, Zoe Jackson, Lynsay Ratcliffe, Kirsty Wainwright, Anna Lovick, Susan C Hickinson, D Mark Wilkinson, Robert W Barry, Simon T Speake, Georgina Ryan, Anderson J Producer: 20110909 In: International journal of oncology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. [electronic resource] by Green, Tim P Fennell, Mike Whittaker, Robin Curwen, Jon Jacobs, Vivien Allen, Jack Logie, Armelle Hargreaves, Judith Hickinson, D Mark Wilkinson, Robert W Elvin, Paul Boyer, Brigitte Carragher, Neil Plé, Patrick A Bermingham, Alun Holdgate, Geoffrey A Ward, Walter H J Hennequin, Laurent F Davies, Barry R Costello, Gerard F Producer: 20120112 In: Molecular oncology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase. [electronic resource] by Barlaam, Bernard Ballard, Peter Bradbury, Robert H Ducray, Richard Germain, Hervé Hickinson, D Mark Hudson, Kevin Kettle, Jason G Klinowska, Teresa Magnien, Françoise Ogilvie, Donald J Olivier, Annie Pearson, Stuart E Scott, James S Suleman, Abid Trigwell, Cath B Vautier, Michel Whittaker, Robin D Wood, Robin Producer: 20080527 In: Bioorganic & medicinal chemistry letters vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)